367 related articles for article (PubMed ID: 19812696)
1. Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.
Rohrbeck A; Borlak J
PLoS One; 2009 Oct; 4(10):e7315. PubMed ID: 19812696
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of lung dysplasia induced by c-Raf-1.
Rohrbeck A; Müller VS; Borlak J
PLoS One; 2009 May; 4(5):e5637. PubMed ID: 19529782
[TBL] [Abstract][Full Text] [Related]
3. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
[TBL] [Abstract][Full Text] [Related]
4. A cross-platform comparison of affymetrix and Agilent microarrays reveals discordant miRNA expression in lung tumors of c-Raf transgenic mice.
Del Vescovo V; Meier T; Inga A; Denti MA; Borlak J
PLoS One; 2013; 8(11):e78870. PubMed ID: 24265725
[TBL] [Abstract][Full Text] [Related]
5. Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar epithelium identifies candidate biomarkers.
Chatterji B; Borlak J
Proteomics; 2007 Nov; 7(21):3980-91. PubMed ID: 17902193
[TBL] [Abstract][Full Text] [Related]
6. Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network.
Reymann S; Borlak J
BMC Syst Biol; 2008 May; 2():46. PubMed ID: 18498649
[TBL] [Abstract][Full Text] [Related]
7. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.
Ciribilli Y; Singh P; Inga A; Borlak J
Oncotarget; 2016 Oct; 7(40):65514-65539. PubMed ID: 27602772
[TBL] [Abstract][Full Text] [Related]
8. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
[TBL] [Abstract][Full Text] [Related]
9. Towards a lung adenocarcinoma proteome map: studies with SP-C/c-raf transgenic mice.
Rütters H; Zürbig P; Halter R; Borlak J
Proteomics; 2006 May; 6(10):3127-37. PubMed ID: 16688788
[TBL] [Abstract][Full Text] [Related]
10. A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice.
Chatterji B; Borlak J
Proteomics; 2009 Feb; 9(4):1044-56. PubMed ID: 19180532
[TBL] [Abstract][Full Text] [Related]
11. Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas.
Li J; Sordella R; Powers S
Sci Rep; 2016 Jun; 6():27891. PubMed ID: 27301828
[TBL] [Abstract][Full Text] [Related]
12. Missense mutations of the BRAF gene in human lung adenocarcinoma.
Naoki K; Chen TH; Richards WG; Sugarbaker DJ; Meyerson M
Cancer Res; 2002 Dec; 62(23):7001-3. PubMed ID: 12460919
[TBL] [Abstract][Full Text] [Related]
13. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
14. Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification.
Rodt T; von Falck C; Dettmer S; Hueper K; Halter R; Hoy L; Luepke M; Borlak J; Wacker F
J Exp Clin Cancer Res; 2012 Feb; 31(1):15. PubMed ID: 22348342
[TBL] [Abstract][Full Text] [Related]
15. A cross-platform comparison of genome-wide expression changes of laser microdissected lung tissue of C-Raf transgenic mice using 3'IVT and exon array.
Londhe KB; Borlak J
PLoS One; 2012; 7(7):e40778. PubMed ID: 22815814
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors.
Reamon-Buettner SM; Borlak J
Cancer Res; 2008 Sep; 68(18):7587-96. PubMed ID: 18794147
[TBL] [Abstract][Full Text] [Related]
17. Conditional expression of oncogenic C-RAF in mouse pulmonary epithelial cells reveals differential tumorigenesis and induction of autophagy leading to tumor regression.
Ceteci F; Xu J; Ceteci S; Zanucco E; Thakur C; Rapp UR
Neoplasia; 2011 Nov; 13(11):1005-18. PubMed ID: 22131876
[TBL] [Abstract][Full Text] [Related]
18. C-Raf is required for the initiation of lung cancer by K-Ras(G12D).
Karreth FA; Frese KK; DeNicola GM; Baccarini M; Tuveson DA
Cancer Discov; 2011 Jul; 1(2):128-36. PubMed ID: 22043453
[TBL] [Abstract][Full Text] [Related]
19. Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.
Gao SB; Feng ZJ; Xu B; Wu Y; Yin P; Yang Y; Hua X; Jin GH
Oncogene; 2009 Nov; 28(46):4095-104. PubMed ID: 19749796
[TBL] [Abstract][Full Text] [Related]
20. Lung tumourigenesis in a conditional Cul4A transgenic mouse model.
Yang YL; Hung MS; Wang Y; Ni J; Mao JH; Hsieh D; Au A; Kumar A; Quigley D; Fang LT; Yeh CC; Xu Z; Jablons DM; You L
J Pathol; 2014 Jun; 233(2):113-23. PubMed ID: 24648314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
